Panax Ginseng per Age-Related Cognitive Decline

Multiple RCTs with mixed but generally positive results for cognitive function. Evidence is not yet convincing for dementia prevention, but acute cognitive enhancement effects are supported by several trials.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dpanax\u002Dginseng\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

In sintesi

Key Study Findings

Animal study

Ginsenoside Rg1 alleviates PCPA-induced insomnia by inhibiting NLRP3 inflammasome activation and pyroptosis through the Nrf2/HO-1 …

Dose: None vs: Placebo Effetto: None None

Review

Advanced nutraceutical approaches to Parkinson's disease: bridging nutrition and neuroprotection.

Dose: None vs: None Outcome: None Effetto: None None

Popolazione: None

Review

Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants.

Dose: None vs: None Outcome: AD pharmacotherapeutic target modulation Effetto: None None

Popolazione: Alzheimer's disease patients (review)

Review

The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review.

Dose: None vs: None Outcome: None Effetto: None None

Popolazione: None

Systematic Review

Dietary Supplement Ingredients for Optimizing Cognitive Performance Among Healthy Adults: A Systematic Review.

Dose: None vs: placebo Outcome: None Effetto: None None

Popolazione: healthy adults

Other

Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6.

Dose: None vs: None Outcome: None Effetto: None None

Popolazione: None

Key Statistics

Studi

1500

Partecipanti

↔

Mixed

Grado

Referenced Papers

Advanced nutraceutical approaches to Parkinson's disease: bridging nutrition and neuroprotection. Review

Nutritional neuroscience 2025 14 citazioni

Ginsenoside Rg1 alleviates PCPA-induced insomnia by inhibiting NLRP3 inflammasome activation and pyroptosis through the Nrf2/HO-1 pathway in mice. Other

Psychopharmacology 2025 5 citazioni

Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants. Review

Degenerative neurological and … 2024 66 citazioni

The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review. Review

Journal of clinical … 2021 38 citazioni

Dietary Supplement Ingredients for Optimizing Cognitive Performance Among Healthy Adults: A Systematic Review. Systematic Review

Journal of alternative … 2021 13 citazioni

Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6. Other

Alzheimer's research & … 2021 1 citazioni

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:: 200-400 mg/day standardized to 4-7% ginsenosides

Limite massimo: Not established; up to 3,000 mg/day used short-term

Dosaggi studiati nella ricerca

Dosaggio	Durata	Effetto	N
None	--	Positive	--
None	--	Mixed	--
None	--	Positive	--
None	--	Mixed	--
None	--	Positive	--
None	--	Positive	--

Momento migliore per l'assunzione: Morning; cycling recommended (8 weeks on, 2 weeks off)

Safety & Side Effects

Effetti collaterali segnalati

⚠ Insomnia
⚠ Headache
⚠ Gastrointestinal discomfort
⚠ Changes in blood pressure
⚠ Rare: hypoglycemia

Interazioni note

● Anticoagulants and antiplatelet drugs
● Antidiabetic drugs (may lower blood sugar)
● MAO inhibitors (may potentiate effects)
● Stimulants (additive stimulatory effects)

Livello di assunzione massimo tollerabile: Not established; up to 3,000 mg/day used short-term

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Panax Ginseng help with Age-Related Cognitive Decline?

Based on 15 studies with 1,500 participants, there is limited but promising evidence that Panax Ginseng may support Age-Related Cognitive Decline management. Our evidence grade is C (Some Evidence).

How much Panax Ginseng should I take for Age-Related Cognitive Decline?

Studies have used various dosages. A commonly studied range is 200-400 mg/day standardized to 4-7% ginsenosides. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Panax Ginseng?

Reported side effects may include Insomnia, Headache, Gastrointestinal discomfort, Changes in blood pressure. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Panax Ginseng and Age-Related Cognitive Decline?

We rate the evidence as Grade C (Some Evidence). This rating is based on 15 peer-reviewed studies with 1,500 total participants. The overall direction of effect is mixed.

Related Evidence

Altri ingredienti per Age-Related Cognitive Decline

Omega-3 Fatty Acids (DHA/EPA) A Phosphatidylserine B Bacopa monnieri B Vitamin B12 B Curcumin B Ginkgo biloba C

Panax Ginseng per altre condizioni

Mental Fatigue C

Verdetto rapido

Evidence Strength52%

Moderate confidence

Analisi degli studi

RCT (0)Meta (0)Other (15)

Confronta le alternative

Scoprite come si confrontano altri ingredienti per questa condizione.

Visualizza tutti gli ingredienti per Age-Related Cognitive Decline

Approfondimenti

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.